Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop.
暂无分享,去创建一个
G. Ott | S. Dave | A. Dogan | M. Wasik | M. Czader | A. Duffield | R. Nejati | J. Cook | J. Goodlad | Catalina Amador | D. Thakkar | Wenbin Xiao | E. Thacker | Lanie E. Happ | Clay Parker
[1] E. Campo,et al. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities , 2022, Virchows Archiv.
[2] C. Mullighan,et al. International Consensus Classification of acute lymphoblastic leukemia/lymphoma , 2022, Virchows Archiv.
[3] E. Cohen,et al. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma , 2022, Haematologica.
[4] W. Chan,et al. Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma , 2022, Virchows Archiv.
[5] R. Siebert,et al. Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape , 2022, Cancers.
[6] A. Rosenwald,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.
[7] L. Staudt,et al. The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. , 2022, Blood.
[8] L. Medeiros,et al. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge , 2021, Modern Pathology.
[9] S. Swerdlow,et al. Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms , 2021, The American journal of surgical pathology.
[10] C. Copie-Bergman,et al. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B , 2021, The American journal of surgical pathology.
[11] C. Copie-Bergman,et al. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas , 2021, The American journal of surgical pathology.
[12] K. Kirito,et al. Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy , 2021, Virchows Archiv.
[13] Cheng Cheng,et al. Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL. , 2021, Blood.
[14] A. Rosenwald,et al. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features , 2021, Virchows Archiv.
[15] G. Ott,et al. Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype , 2020, Haematologica.
[16] D. Scott,et al. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma. , 2020, Cancer discovery.
[17] S. Pileri,et al. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas , 2020, iScience.
[18] C. June,et al. Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of epigenome. , 2020, Blood.
[19] Ryan D. Morin,et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. , 2020, Cancer cell.
[20] S. Barrans,et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. , 2020, Blood.
[21] R. Advani,et al. Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics. , 2020, Blood advances.
[22] S. Bens,et al. Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma , 2020, Haematologica.
[23] S. Barrans,et al. Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit , 2019, Leukemia.
[24] E. Campo,et al. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy , 2019, Journal of Experimental & Clinical Cancer Research.
[25] Ryan D. Morin,et al. --The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. , 2019, Blood.
[26] A. Rosenwald,et al. Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] T. Klausen,et al. Stratification by MYC expression has prognostic impact in MYC translocated B‐cell lymphoma—Identifies a subgroup of patients with poor outcome , 2019, European journal of haematology.
[28] Ryan D. Morin,et al. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] S. Barrans,et al. Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] W. Klapper,et al. IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. , 2018, Blood.
[31] Ryan D. Morin,et al. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. , 2018, Blood advances.
[32] P. Brousset,et al. Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements , 2018, Haematologica.
[33] R. Bociek,et al. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations. , 2018, Human pathology.
[34] E. Jabbour,et al. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma , 2018, Modern Pathology.
[35] J. Cerhan,et al. Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements , 2018, Haematologica.
[36] Y. Oki,et al. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas , 2018, Modern Pathology.
[37] A. Rosenwald,et al. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology. , 2018, Blood.
[38] Stefano Monti,et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.
[39] Roland Schmitz,et al. Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma , 2018, The New England journal of medicine.
[40] L. Medeiros,et al. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma , 2017, Modern Pathology.
[41] M. Keating,et al. Richter transformation of CLL , 2016, Expert review of hematology.
[42] R. Advani,et al. The World Health Organization Classification of Lymphoid Neoplasms , 2013 .
[43] A. Zelenetz,et al. Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma , 2016, Cancer.
[44] M. Konopleva,et al. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis , 2015, Pediatric hematology and oncology.
[45] A. Rosenwald,et al. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum , 2015, Leukemia.
[46] O. Elemento,et al. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. , 2015, Human pathology.
[47] R. Spang,et al. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma , 2014, Haematologica.
[48] M. Calaminici,et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.
[49] W. Choi,et al. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. , 2012, Blood.
[50] K. Ohshima,et al. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma , 2012, Pathology international.
[51] A. Lauritzen,et al. Double‐hit BCL2/MYC translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experience , 2012, European journal of haematology.
[52] L. Medeiros,et al. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome , 2012, Modern Pathology.
[53] I. Lossos,et al. Transformation of follicular lymphoma. , 2011, Best practice & research. Clinical haematology.
[54] Philip M Kluin,et al. Double-hit B-cell lymphomas. , 2011, Blood.
[55] S. Barrans,et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] A. Rosenwald,et al. IgVH Mutational Status and Clonality Analysis of Richter's Transformation: Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma in Association With B-cell Chronic Lymphocytic Leukemia (B-CLL) Represent 2 Different Pathways of Disease Evolution , 2007, The American journal of surgical pathology.
[57] F. Jardin,et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas , 2007, Leukemia.
[58] L. Kopper,et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome , 2004, Leukemia.
[59] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[60] G. Ott,et al. Pathology of lymphoma progression , 2001, Histopathology.
[61] D. Head,et al. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience , 1999, Leukemia.
[62] T. Lister,et al. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease. , 1994, Leukemia.
[63] M. Raffeld,et al. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus. , 1993, American journal of clinical pathology.
[64] M. Stetler-Stevenson,et al. Involvement of the bcl-2 gene in Hodgkin's disease. , 1990, Journal of the National Cancer Institute.